期刊文献+

辛伐他丁对淋巴瘤CA46细胞凋亡的影响及机制 被引量:1

Simvastatin induces apoptosis of lymphoma CA46 cells and its underlying mechanisms
下载PDF
导出
摘要 目的:研究内源性胆固醇合成限速酶(HMG-CoA)还原酶抑制剂辛伐他汀对淋巴瘤细胞凋亡的影响及分子机制。方法:辛伐他汀对淋巴瘤CA46细胞株进行干预,MTT法评价二者对癌细胞增殖的影响;流式细胞计量术检测细胞凋亡;免疫印迹法检测凋亡相关蛋白多聚ADP核糖多聚糖蛋白(PARP)、半胱氨酸蛋白酶-3(Caspase-3)、凋亡相关基因Bax、Bcl-2表达情况。结果:辛伐他汀干预可显著抑制CA46细胞MTT活性,辛伐他汀作用还可促进CA46细胞凋亡的启动,且均呈剂量-效应关系;辛伐他汀干预还可引发CA46肿瘤细胞Caspase-3活性水平升高,PARP裂解失活,促凋亡蛋白Caspase-3、Bax高表达,抗凋亡蛋白Bcl-2表达降低,且均呈现时间-效应关系。结论:辛伐他汀对淋巴瘤CA46细胞具有增殖抑制和促凋亡效应,其机制可能与caspase家族介导的蛋白酶级联反应、PARP裂解失活以及Bcl-2家族介导的细胞色素C途径有关。 Objective. To investigate the anti proliferative effects of simvastatin on lymphoma cells and its underlying mechanisms. Methods:CA46 cells were interfered by Simvastatin, MTT assay was used to evaluate the anti-proliferative effects, Flow cytometry assay was used to detect apoptosis; Western blot analysis was used to detect the protein expression of PAP, P, Caspase-3 and apoptosis-related molecules Bax.Bcl-2. Results= The MTT and FCM data shows that Simvastatin inhibited activity of CA46 cell, and caused apoptosis of CA46 cell in a dose-dependent manner. The expression level of Caspase-3 and cleavage of PARP was significantly increased when treated with simvastatin. The expression of Bax was also in-
出处 《海南医学院学报》 CAS 2014年第2期165-168,共4页 Journal of Hainan Medical University
基金 内蒙古自然科学基金(2013MS1188)~~
关键词 辛伐他汀 淋巴瘤 CA46 细胞凋亡 Simvastatin Lymphoma CA46 Apoptosis
  • 相关文献

参考文献14

  • 1Hanada M,Delia D,Aiello A. Bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia[J].{H}Blood,2013,(05):1820-1828.
  • 2Benekli M,Baer MR,Baumann H. Signal transducer and activator of transcription proteins in leukemias[J].{H}Blood,2013,(05):2940-2954.
  • 3Qi XF,Kim DH,Yoon YS. Fluvastatin inhibits expression of the chemokine MDC/CCL22 induced by interferon-gamma in HaCaT cells,a human keratinocyte cell line[J].{H}British Journal of Pharmacology,2009,(05):1441-1450.
  • 4Kotamraju S,Williams CL,Kalyanaraman B. Statin-induced breast cancer cell death:role of inducible nitric oxide and arginase-dependent pathways[J].{H}CANCER RESEARCH,2012,(07):7386-7394.
  • 5Koyuturk M,Ersoz M,Altiok N. Simvastatin induces apoptosis in human breast cancer cells:p53 and estrogen receptor independent pathway requiring signalling through JNK[J].{H}CANCER LETTERS,2012,(01):220-228.
  • 6Tu YS,Kang XL,Zhou JG. Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells[J].{H}EUROPEAN JOURNAL OF PHARMACOLOGY,2011,(01):356-364.
  • 7Pelaia G,Gallelli L,Renda T. Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation,apoptosis and cell viability in nonsmall lung cancer cells[J].{H}CELL PROLIFERATION,2012,(01):557-565.
  • 8Cemeus C,Zhao TT,Barrett GM. Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvⅢ and PTEN status[J].{H}Journal of Neuro-Oncology,2012,(01):9-17.
  • 9Sanchez CA,Rodriguez E,Varela E. Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress[J].{H}CANCER INVESTIGATION,2012,(01):698707.
  • 10Yamazaki H,Suzuki M,Aoki T. Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ubiquinone levels in rat skeletal muscle and heart:relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cells[J].{H}Journal of Atherosclerosis and Thrombosis,2013,(01):295-307.

同被引文献25

  • 1曾毅.不同剂量辛伐他汀对高血压并高血脂患者内皮功能的影响[J].中国老年学杂志,2014,34(2):355-356. 被引量:35
  • 2Zhou Q, Liao JK. Pleiotropic effects of statins. -Basic research and clinical perspectives-[ J]. Circ J,2010,7d(5) :818-826.
  • 3Motayama K, Fukumoto S, Koyama H, et al. SREBP inhibits VEGF expression in human smooth muscle cells [ J ]. Biochem Biophys Res Commun,2006,342 ( 1 ) : 354-360.
  • 4Frick M, Dulak J, Cisowski J, et al. Statins differentially regulate vascular endothdial growth factor synthesis in endothelial and vascular smooth muscle cells [ J ]. Atherosclerosis ,2003,170 (2) :229-236.
  • 5Dichtl W, Dulak J, Frick M, et at. HMG-CoA reduetase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells [ J]. Arterioseler Thromb Vasc Biol, 2003,23 ( 1 ) :58-63.
  • 6Kusama T, Mukai M, Iwasaki T, et al. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors [J]. Cancer Res,2001,61 (12) :4885-4891.
  • 7Li G, Larson EB, Sonnen JA, et al. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease [ J ]. Neurology ,2007,69 (9) :878-885.
  • 8Sparks DL, Sabbagh MN, Connor DJ, et al. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary resuhs [ J ]. Arch Neuro1,2005,62 ( 5 ) :753-757.
  • 9Htiglund K, Blennow K. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease [ J]. CNS Drugs,2007,21 (6) :449-462.
  • 10赵佼,董云霞.他汀类药物的临床应用及不良反应[J].实用药物与临床,2008,11(4):243-244. 被引量:33

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部